# EDGAR Filing Document

**Accession Number:** 0001831006
**File Stem:** 0001104659-23-006592
**Filing Date:** 2023-1
**Character Count:** 50417
**Document Hash:** fe8541297c805344ca7ba30b8fc41548
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-006592.hdr.sgml**: 20230125

**ACCESSION NUMBER**: 0001104659-23-006592

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230125

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230125

**DATE AS OF CHANGE**: 20230125

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlueRiver Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001831006
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39961
- **FILM NUMBER:** 23553148

**BUSINESS ADDRESS:**
- **STREET 1:** 250 WEST NOTTINGHAM DRIVE
- **STREET 2:** SUITE 400
- **CITY:** SAN ANTONIO
- **STATE:** TX
- **ZIP:** 78209
- **BUSINESS PHONE:** 000-000-0000

**MAIL ADDRESS:**
- **STREET 1:** 250 WEST NOTTINGHAM DRIVE
- **STREET 2:** SUITE 400
- **CITY:** SAN ANTONIO
- **STATE:** TX
- **ZIP:** 78209

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): January 25, 2023**

**BlueRiver Acquisition Corp.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-39961** | **98-1577027** |
| **(State or other jurisdiction of incorporation or <br> organization)** | **(Commission File<br> Number)** | **(I.R.S. Employer Identification <br> Number)** |

---

---

| | |
|:---|:---|
| **250 West Nottingham Drive, Suite 400<br> San Antonio, Texas**  | **78209** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (210) 832 3305**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⌧ Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br> Symbol(s)** | **Name of each exchange<br> on which registered** |
| **Units, each consisting of one Class A ordinary share and one-third of a redeemable Warrant to acquire one Class A ordinary share** | **BLUA.U** | **The New York Stock Exchange** |
| **Class A ordinary share, par value $0.0001 per share** | **BLUA** | **The New York Stock Exchange** |
| **Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50** | **BLUA.WS** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 1.01. Entry into a Material Definitive Agreement.**

On January 25, 2023, BlueRiver Acquisition Corp. (the "Company") and BlueRiver Ventures, LLC (the "Sponsor"), the sponsor of the Company, entered into a non-redemption agreement ("Non-Redemption Agreement") with one or more unaffiliated third party or parties in exchange for such third party or third parties agreeing not to redeem an aggregate of 200,000 shares of the Company sold in its initial public offering ("Non-Redeemed Shares") at the special meeting called by the Company (the "Special Meeting") to approve an extension of time for the Company to consummate an initial business combination (the "Extension Proposal") from February 2, 2023 to August 2, 2023 (the "Extension"). In exchange for the foregoing commitments not to redeem such shares, the Sponsor has agreed to transfer to such third party or third parties an aggregate of 50,000 shares of the Company held by the Sponsor immediately following consummation of an initial business combination if they continue to hold such Non-Redeemed Shares through the Special Meeting. The Non-Redemption Agreements are not expected to increase the likelihood that the Extension Proposal is approved by Company shareholders but will increase the amount of funds that remain in the Company's trust account following the Special Meeting. The foregoing summary of the Non-Redemption Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed herein as Exhibit 10.1 and incorporated herein by reference.

**Forward-Looking Statements**

This Current Report on Form 8-K (the "Report") includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, the risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"). Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

**Participants in the Solicitation**

The Company and its directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the securityholders of the Company in favor of the approval of the Extension Proposal. Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and officers in the definitive proxy statement dated January 13, 2023 (the "Proxy Statement"), which may be obtained free of charge from the sources indicated below.

**No Offer or Solicitation**

This Report shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

**Additional Information and Where to Find It**

The Company urges investors, shareholders and other interested persons to read the Proxy Statement as well as other documents filed by the Company with the SEC, because these documents will contain important information about the Company and the Extension Proposal. Shareholders may obtain copies of the Proxy Statement, without charge, at the SEC's website at *www.sec.gov* or by directing a request to the Company's proxy solicitor, Okapi Partners, at 1212 Avenue of the Americas, 17th Floor, New York, NY 10036, Toll-Free (855) 208-8903 or (212) 297-0720, Email: info@okapipartners.com.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [10.1](tm234432d1_ex10-1.htm) | [Form of Non-Redemption Agreement](tm234432d1_ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **BlueRiver Acquisition Corp.** | **BlueRiver Acquisition Corp.** |
| By: | /s/ John Gregg  |
| Name: | John Gregg |
| Title: | Co-Chief Executive Officer |

---

Dated: January 25, 2023

## Exhibit 10.1

**Exhibit 10.1**

**NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST**

This Non-Redemption Agreement and Assignment of Economic Interest (this "<u>Agreement</u>") is entered as of [●], 2023 by and among BlueRiver Acquisition Corp. ("<u>BLUA</u>"), BlueRiver Ventures, LLC (the "<u>Sponsor</u>") and the undersigned investor ("<u>Investor</u>").

**RECITALS**

**WHEREAS**, the Sponsor currently holds BLUA Class B ordinary shares initially purchased in a private placement prior to BLUA's initial public offering (the "<u>Founder Shares</u>");

**WHEREAS**, BLUA expects to hold an extraordinary general meeting of shareholders (the "<u>Meeting</u>") for the purpose of approving, among other things, an amendment to BLUA's Amended and Restated Memorandum and Articles of Association (the "<u>M&A</u>") to extend the date by which BLUA must consummate an initial business combination (the "<u>Initial Business Combination</u>") for up to six additional months until as late as August 2, 2023 (the "<u>Extension</u>");

**WHEREAS**, the M&A provides that a shareholder of BLUA may redeem its Class A ordinary shares, par value $0.0001 per share, initially sold as part of the units in BLUA's initial public offering (whether they were purchased in our initial public offering or thereafter in the open market) (the "<u>Public Shares</u>" and together with the Founder Shares, the "<u>Ordinary Shares</u>") in connection with the M&A amendment, on the terms set forth in the M&A ("<u>Redemption Rights</u>");

**WHEREAS**, subject to the terms and conditions of this Agreement, the Sponsor desires to transfer to Investor, and Investor desires to acquire from the Sponsor, that number of Founder Shares set forth opposite such Investor's name on <u>Exhibit A</u> (the "<u>Assigned Securities</u>"), to be transferred to Investor in connection with BLUA's completion of its Initial Business Combination, and, prior to the transfer of the Assigned Securities to Investor, the Sponsor desires to assign the economic benefits of the Assigned Securities to Investor.

**NOW THEREFORE**, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Investor and the Sponsor hereby agree as follows:

1. <u>Terms of Transfer</u>.

1.1. Upon the terms and subject to the conditions of this Agreement, the Sponsor agrees that if (a) as of 5:00 PM, New York time, on the date of the Meeting, Investor holds the Investor Shares (as defined below), (b) Investor does not exercise its Redemption Rights with respect to such Investor Shares in connection with the Meeting, and (c) the Extension is approved at the Meeting and is effected by BLUA's filing with the registrar of the Cayman Islands of the Amended and Restated Memorandum and Articles of Association, then the Sponsor hereby agrees to assign to Investor for no additional consideration the Assigned Securities set forth on <u>Exhibit A</u>, and the Sponsor agrees to assign to Investor the Economic Interest (as defined below) associated with the Assigned Securities that the Sponsor has agreed to assign to Investor. "Investor Shares" shall mean the lesser of (i) [200,000] Public Shares, and (ii) 9.9% of the Public Shares that are not to be redeemed, including those Public Shares subject to non-redemption agreements with other BLUA shareholders similar to this Agreement as of [●], 2023. The Sponsor and BLUA agree to provide Investor with the final number of Investor Shares subject to this Agreement no later than 9:00 a.m. Eastern on February 3, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;1.2. The Sponsor and Investor hereby agree that the assignment of the Assigned Securities shall be subject to the conditions that (i) the
Initial Business Combination is consummated; and (ii) Investor (or its Permitted Transferees (as such term is defined in the Amended
and Restated Limited Liability Company Agreement of the Sponsor (as it exists on the date hereof, the " <u>Sponsor LLC Agreement</u> ")
executes a joinder to that certain Letter Agreement, dated January 28, 2021 (as it exists on the date hereof, the " <u>Letter Agreement</u> "), by and among the Company, the Sponsor, officers and directors of the Company, and the other shareholders of the
Company signatory thereto, as described in Section 1.8 hereof.

Upon the satisfaction of the foregoing conditions, as applicable, the Sponsor shall promptly transfer the Assigned Securities to Investor (or its Permitted Transferees). The Sponsor covenants and agrees to facilitate such transfer to Investor (or its Permitted Transferees) in accordance with the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;1.3. <u>Adjustment to Share Amounts</u>. If at any time the number of outstanding Founder Shares is increased or decreased by a consolidation,
combination, subdivision or reclassification of the Ordinary Shares of BLUA or other similar event, then, as of the effective date of
such consolidation, combination, subdivision, reclassification or similar event, all share numbers referenced in this Agreement shall
be adjusted in proportion to such increase or decrease in the Ordinary Shares.

&nbsp;&nbsp;&nbsp;&nbsp;1.4. <u>Merger or Reorganization, etc</u>. If there shall occur any reorganization, recapitalization, reclassification, consolidation
or merger involving BLUA in which its Ordinary Shares are converted into or exchanged for securities, cash or other property, then, following
any such reorganization, recapitalization, reclassification, consolidation or merger, in lieu of ordinary shares of BLUA, the Sponsor
shall transfer, with respect to each Founder Share to be transferred hereunder, upon the Sponsor's receipt thereof, the kind and
amount of securities, cash or other property into which such Assigned Securities converted or exchanged.

&nbsp;&nbsp;&nbsp;&nbsp;1.5. <u>Forfeitures, Transfers, etc.</u> Investor shall not be required to forfeit or transfer the Assigned Securities. Investor acknowledges
that, pursuant to the Sponsor LLC Agreement, prior to, or at the time of, the Initial Business Combination, the Managers of the Sponsor
have the authority to cause the Sponsor to subject the Founder Shares to earn-outs, forfeitures, transfers or other restrictions, or amend
the terms under which the Founder Shares were issued or any restrictions or other provisions relating to the Founder Shares set forth
in the instruments establishing the same (including voting in favor of any such amendment) or enter into any other arrangements with respect
to the Founder Shares, and that the Managers are authorized to effectuate such earn-outs, forfeitures, transfers, restrictions, amendments
or arrangements, including arrangements relating to the relaxation or early release of restrictions, in such amounts and pursuant to such
terms as they determine in their sole and absolute discretion for any reason. Sponsor acknowledges and agrees that any such earn-outs,
forfeitures, transfers, restrictions, amendments or arrangements shall apply only to the Founder Shares other than the Assigned Securities
and the terms and conditions applicable to the Assigned Securities shall not be changed as a result of any such earn-outs, forfeitures,
transfers, restrictions, amendments or arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;1.6. <u>Delivery of Shares; Other Documents.</u> At the time of the transfer of Assigned Securities hereunder, the Sponsor shall deliver
the Assigned Securities to Investor by transfer of book-entry shares effected through BLUA's transfer agent. The parties to this
Agreement agree to execute, acknowledge and deliver such further instruments and to do all such other acts, as may be necessary or appropriate
to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.7. <u>Assignment of Registration Rights</u>. Concurrent with the transfer of Assigned Securities to Investor under this Agreement, the
Sponsor hereby assigns all of its rights, duties and obligations to Investor with respect to the Assigned Securities under that certain
Registration Rights Agreement, dated January 28, 2021 (as it exists on the date of the Agreement, the " <u>Registration Rights Agreement</u> "), by and among the Company, the Sponsor, and the other shareholders of the Company signatory thereto, and hereby
represents and confirms to Investor that, upon Investor's receipt of the Assigned Securities, (i) Investor shall be a "Holder"
under the Registration Rights Agreement and (ii) the Assigned Securities shall be "Registrable Securities" under the
Registration Rights Agreement. The Sponsor shall provide written notice to BLUA of such assignment in accordance with the Registration
Rights Agreement. Investor shall provide to BLUA a written agreement in accordance with the Registration Rights Agreement agreeing to
be bound by the terms and provisions of the Registration Rights Agreement as a "Holder" thereunder with respect to the Assigned
Securities (upon acquisition thereof) as "Registrable Securities" thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;1.8. <u>Joinder to Letter Agreement</u>. In connection with the transfer of the Assigned Securities to Investor, Investor shall execute
a joinder to the Letter Agreement in substantially the form attached here to as <u>Exhibit B</u> (the " <u>Joinder</u> ")
pursuant to which Investor shall agree with BLUA to be bound solely by Section 5(a) of the Letter Agreement solely with respect
to the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;1.9. <u>Termination.</u> This Agreement and each of the obligations
 of the undersigned shall terminate on earlier of (a) the failure of BLUA's shareholders
 to approve the Extension at the Meeting, or the determination of BLUA not to proceed to effect
 the Extension, (b) the fulfillment of all obligations of parties hereto, (c) the liquidation
 or dissolution of BLUA, (d) the mutual written agreement of the parties hereto; or (e) if
 Investor exercises its Redemption Rights with respect to any Investor Shares in connection
 with the Meeting and such Redemption Rights are not withdrawn by the date of the Meeting.
 Notwithstanding any provision in this Agreement to the contrary, the Sponsor's obligation
 to transfer the Assigned Securities to Investor shall be conditioned on (i) the satisfaction
 of the conditions set forth in Section 1.2 and (ii) Investor not exercising its Redemption
 Rights with respect to such Investor Shares in connection with the Meeting.

2. <u>Assignment of Economic Interest</u>.

&nbsp;&nbsp;&nbsp;&nbsp;2.1. Upon satisfaction of the conditions set forth in Section 1.1, the Sponsor hereby assigns to Investor all of its economic right,
title and interest in and to that number of Assigned Securities set forth on <u>Exhibit A</u> (the " <u>Economic Interest</u> "),
subject to adjustment as set forth in Section 2.2. The Economic Interest represents the Sponsor's right to receive dividends
and other distributions made by the Sponsor pursuant to the Sponsor LLC Agreement allocated to that number of Assigned Securities set
forth on <u>Exhibit A</u> represented by the Founder Shares held directly by the Sponsor.

&nbsp;&nbsp;&nbsp;&nbsp;2.2. Investor acknowledges and agrees that it has no right to vote on matters of the Sponsor as a result of the Assigned Securities or
Economic Interest, or to vote with respect to any Assigned Securities, and it has no right to vote Assigned Securities prior to transfer
of any such shares to Investor pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2.3. Investor acknowledges and agrees that if it has a right pursuant to its Economic Interest to receive any dividends or other distributions
paid in Ordinary Shares or other non-cash property, the Sponsor shall transfer all of its right, title and interest in such dividends
or distributions concurrently with the transfer of the Assigned Securities to such Investor pursuant to Section 1.

&nbsp;&nbsp;&nbsp;&nbsp;2.4. If the conditions to the transfer of the Founder Shares in Section 1 are not satisfied with respect to any Founder Shares, then
Investor shall automatically assign its Economic Interests in such Founder Shares back to the Sponsor, for no consideration.

3. <u>Representations and Warranties of Investor</u>. Investor represents and warrants to, and agrees with, the Sponsor that:

&nbsp;&nbsp;&nbsp;&nbsp;3.1. <u>No Government Recommendation or Approval</u>. Investor understands that no federal or state agency has passed upon or
made any recommendation or endorsement of the offering of the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.2. <u>Accredited Investor</u>. Investor is an "accredited investor" as such term is defined in Rule 501(a) of Regulation
D under the Securities Act of 1933, as amended (the " <u>Securities Act</u> "), and acknowledges that the sale contemplated
hereby is being made in reliance, among other things, on a private placement exemption to "accredited investors" under the
Securities Act and similar exemptions under state law.

&nbsp;&nbsp;&nbsp;&nbsp;3.3. <u>Intent</u>. Investor is acquiring the Assigned Securities solely for investment purposes, for such Investor's
own account (and/or for the account or benefit of its members or affiliates, as permitted), and not with a view to the distribution thereof
in violation of the Securities Act and Investor has no present arrangement to sell Assigned Securities to or through any person or entity
except as may be permitted hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;3.4. <u>Restrictions on Transfer; Trust Account; Redemption Rights</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.1. Investor acknowledges and agrees that, prior to their transfer hereunder, the Assigned Securities are, and following any transfer
to Investor may continue to be, subject to the Transfer Restrictions and certain other restrictions as set forth in the Letter Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.2. Investor acknowledges and agrees that the Assigned Securities are not entitled to, and have no right, interest or claim of any kind
in or to, any monies held in the trust account into which the proceeds of BLUA's initial public offering were deposited (the " <u>Trust Account</u> ") or distributed as a result of any liquidation of the Trust Account.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.3. Investor waives any right that it may have to elect to have
BLUA redeem any Investor Shares and agrees not to redeem or otherwise exercise any right to redeem, the Investor Shares and to reverse
and revoke any prior redemption elections made with respect to the Investor Shares in connection with the Extension. For the avoidance
of doubt, nothing in this Agreement is intended to restrict or prohibit Investor's ability to redeem any Public Shares other than
the Investor Shares, or to trade or redeem any Public Shares (other than the Investor Shares) in its discretion and at any time or any
Investor Shares in its discretion and at any time after February 2, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.4. Investor acknowledges and understands the Assigned Securities are being offered in a transaction not involving a public offering in
the United States within the meaning of the Securities Act and have not been registered under the Securities Act and, if in the future
Investor decides to offer, resell, pledge or otherwise transfer Assigned Securities, such Assigned Securities may be offered, resold,
pledged or otherwise transferred only (A) pursuant to an effective registration statement filed under the Securities Act, (B) pursuant
to an exemption from registration under Rule 144 promulgated under the Securities Act, if available, or (C) pursuant to any
other available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable
securities laws of any state or any other jurisdiction. Investor agrees that, if any transfer of the Assigned Securities or
any interest therein is proposed to be made, as a condition precedent to any such transfer, Investor may be required to deliver to
BLUA an opinion of counsel satisfactory to BLUA that registration is not required with respect to the Assigned Securities to be transferred.
Absent registration or another available exemption from registration, Investor agrees it will not transfer the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.5. <u>Voting</u>. Investor agrees that it will and will cause its controlled affiliates to vote (or cause to be voted) or execute and
deliver a written consent (or cause a written consent to be executed and delivered) all of BLUA Ordinary Shares owned, as of the applicable
record date, by any of them at the Meeting in favor of the Extension and cause all such shares to be counted as present at the Meeting
for purposes of establishing a quorum.

&nbsp;&nbsp;&nbsp;&nbsp;3.6. <u>Sophisticated Investor</u>. Investor is sophisticated in financial matters and able to evaluate the risks and benefits of the investment
in the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;3.7. <u>Risk of Loss</u>. Investor is aware that an investment in the Assigned Securities is highly speculative and subject to substantial
risks. Investor is cognizant of and understands the risks related to the acquisition of the Assigned Securities, including those restrictions
described or provided for in this Agreement, the Sponsor LLC Agreement and the Letter Agreement pertaining to transferability. Investor
is able to bear the economic risk of its investment in the Assigned Securities for an indefinite period of time and able to sustain a
complete loss of such investment.

&nbsp;&nbsp;&nbsp;&nbsp;3.8. <u>Independent Investigation</u>. Investor has relied upon an independent investigation of BLUA and has not relied upon
any information or representations made by any third parties or upon any oral or written representations or assurances, express or implied,
from the Sponsor or any representatives or agents of the Sponsor, other than as set forth in this Agreement. Investor is familiar with
the business, operations and financial condition of BLUA and has had an opportunity to ask questions of, and receive answers from BLUA's
management concerning BLUA and the terms and conditions of the proposed sale of the Assigned Securities and has had full access to such
other information concerning BLUA as Investor has requested. Investor confirms that all documents that it has requested have been made
available and that Investor has been supplied with all of the additional information concerning this investment which Investor has requested.

&nbsp;&nbsp;&nbsp;&nbsp;3.9. <u>Organization and Authority</u>. If any entity, Investor is duly organized and existing under the laws of the jurisdiction
in which it was organized and it possesses all requisite power and authority to acquire the Assigned Securities, enter into this Agreement
and perform all the obligations required to be performed by Investor hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;3.10. <u>Non-U.S. Investor</u>. If Investor is not a United States
person (as defined by Section 7701(a)(30) of the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated
thereunder (collectively, the " <u>Code</u> ")), Investor hereby represents that it has satisfied itself as to the full
observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Assigned Securities or any use of this
Agreement, including (i) the legal requirements within its jurisdiction for the acquisition of the Assigned Securities, (ii) any
foreign exchange restrictions applicable to such acquisition, (iii) any governmental or other consents that may need to be obtained,
and (iv) the income tax and other tax consequences, if any, that may be relevant to the acquisition, holding, redemption, sale,
or transfer of the Assigned Securities. Investor's subscription and payment for and continued beneficial ownership of the Assigned
Securities will not violate any applicable securities or other laws of Investor's jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;3.11. <u>Authority</u>. This Agreement has been validly authorized, executed and delivered by Investor and is a valid and binding agreement
enforceable in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent
conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors' rights
and remedies or by equitable principles of general application and except as enforcement of rights to indemnity and contribution may be
limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;3.12. <u>No Conflicts</u>. The execution, delivery and performance of this Agreement and the consummation by Investor of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (i) Investor's organizational documents, (ii) any
agreement or instrument to which Investor is a party or (iii) any law, statute, rule or regulation to which Investor is subject,
or any order, judgment or decree to which Investor is subject, in the case of clauses (ii) and (iii), that would reasonably be expected
to prevent Investor from fulfilling its obligations under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.13. <u>No Advice from Sponsor</u>. Investor has had the opportunity to review this Agreement and the transactions contemplated by this
Agreement and the form of Letter Agreement with Investor's own legal counsel and investment and tax advisors. Except
for any statements or representations of the Sponsor explicitly made in this Agreement, Investor is relying solely on such counsel
and advisors and not on any statements or representations, express or implied, of the Sponsor or any of its representatives or agents
for any reason whatsoever, including without limitation for legal, tax or investment advice, with respect to this investment, the Sponsor,
BLUA, the Assigned Securities, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;3.14. <u>Reliance on Representations and Warranties</u>. Investor understands that the Assigned Securities are being offered
and sold to Investor in reliance on exemptions from the registration requirements under the Securities Act, and analogous provisions in
the laws and regulations of various states, and that the Sponsor is relying upon the truth and accuracy of the representations, warranties,
agreements, acknowledgments and understandings of Investor set forth in this Agreement in order to determine the applicability of such
provisions.

&nbsp;&nbsp;&nbsp;&nbsp;3.15. <u>No General Solicitation</u>. Investor is not subscribing for Assigned Securities as a result of or subsequent to any
general solicitation or general advertising, including but not limited to any advertisement, article, notice or other communication published
in any newspaper, magazine, or similar media or broadcast over television or radio or any seminar or meeting whose attendees have been
invited by any general solicitation or general advertising.

&nbsp;&nbsp;&nbsp;&nbsp;3.16. <u>Brokers</u>. No broker, finder or intermediary has been paid or is entitled to a fee or commission from or by Investor in
connection with the acquisition of the Assigned Securities nor is Investor entitled to or will accept any such fee or commission.

4. <u>Representations and Warranties of Sponsor.</u> The Sponsor represents and warrants to, and agrees with, the Investor that:

&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Power and Authority</u>. The Sponsor is a limited liability company duly formed and validly existing and in good standing
as a limited liability company under the laws of the Cayman Islands and possesses all requisite limited liability company power and authority
to enter into this Agreement and to perform all of the obligations required to be performed by the Sponsor hereunder, including the assignment,
sale and transfer the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;4.2. <u>Authority</u>. All corporate action on the part of the Sponsor
and its officers, directors and members necessary for the authorization, execution and delivery of this Agreement and the performance
of all obligations of the Sponsor required pursuant hereto has been taken. This Agreement has been duly executed and delivered by the
Sponsor and (assuming due authorization, execution and delivery by Investor) constitutes the Sponsor's legal, valid and binding
obligation, enforceable against the Sponsor in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement
of, creditors' rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity
and contribution may be limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;4.3. <u>Title to Securities</u>. The Sponsor is the record and beneficial owner of, and has good and marketable title to, the Assigned
Securities and will, immediately prior to the transfer of the Assigned Securities to Investor, be the record and beneficial owner of the
Assigned Securities, in each case, free and clear of all liens, pledges, security interests, charges, claims, encumbrances, agreements,
options, voting trusts, proxies and other arrangements or restrictions of any kind (other than transfer restrictions and other terms and
conditions that apply to the Founder Shares generally and applicable securities laws). The Assigned Securities to be transferred, when
transferred to Investor as provided herein, will be free and clear of all liens, pledges, security interests, charges, claims, encumbrances, agreements,
options, voting trusts, proxies and other arrangements or restrictions of any kind (other than transfer restrictions and other terms and
conditions that apply to the Founder Shares generally, under the Letter Agreement and applicable securities laws).

&nbsp;&nbsp;&nbsp;&nbsp;4.4. <u>No Conflicts</u>. The execution, delivery and performance of this Agreement and the consummation by the Sponsor of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (i) the certificate of formation or the Sponsor LLC
Agreement, (ii) any agreement or instrument to which the Sponsor is a party or by which it is bound (including the Letter Agreement
and the Sponsor LLC Agreement) or (iii) any law, statute, rule or regulation to which the Sponsor is subject or any order, judgment
or decree to which the Sponsor is subject. The Sponsor is not required under federal, state or local law, rule or regulation to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency or self-regulatory entity
in order for it to perform any of its obligations under this Agreement or transfer the Assigned Securities in accordance with the terms
hereof.

&nbsp;&nbsp;&nbsp;&nbsp;4.5. <u>No General Solicitation</u>. The Sponsor has not offered the Assigned Securities by means of any general solicitation
or general advertising within the meaning of Regulation D of the Securities Act, including but not limited to any advertisement, article,
notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio or any seminar
or meeting whose attendees have been invited by any general solicitation or general advertising.

&nbsp;&nbsp;&nbsp;&nbsp;4.6. <u>Brokers</u>. No broker, finder or intermediary has been paid or is entitled to a fee or commission from or by the Sponsor
in connection with the sale of the Assigned Securities nor is the Sponsor entitled to or will accept any such fee or commission.

&nbsp;&nbsp;&nbsp;&nbsp;4.7. <u>Transfer Restrictions</u>. Until termination of this Agreement, the Sponsor shall not transfer any of its Founder Shares representing
the economic benefit of the Assigned Securities other than any transfer pursuant to the Sponsor LLC Agreement in connection with an Initial
Business Combination.

&nbsp;&nbsp;&nbsp;&nbsp;4.8. <u>Reliance on Representations and Warranties</u>. The Sponsor understands and acknowledges that Investor is relying upon
the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Sponsor set forth in
this Agreement.

5. <u>Trust Account</u>. Until the earlier of (a) the consummation of BLUA's initial business combination; (b) the liquidation
of the Trust Account; and (c) 24 months from consummation of BLUA's initial public offering or such later time as the shareholders
of BLUA may approve in accordance with the M&A, BLUA will maintain the investment of funds held in the Trust Account in interest-bearing
United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having
a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of
Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury
obligations, or maintain such funds in cash in an interest-bearing demand deposit account at a bank.

6. <u>Governing Law; Jurisdiction; Waiver of Jury Trial</u>. This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect
to its principles or rules of conflict of laws to the extent such principles or rules would require or permit the application
of the laws of another jurisdiction. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant
to this Agreement and the transactions contemplated hereby. With respect to any suit, action or proceeding relating to the transactions
contemplated hereby, the undersigned irrevocably submit to the jurisdiction of the United States District Court or, if such court does
not have jurisdiction, the New York state courts located in the Borough of Manhattan, State of New York, which submission shall be exclusive.

7. <u>Assignment; Entire Agreement; Amendment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Assignment</u>. Any assignment of this Agreement or any right, remedy, obligation or liability arising hereunder by either
the Sponsor or Investor to any person that is not an affiliate of such party shall require the prior written consent of the other party.

&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Entire Agreement</u>. This Agreement sets forth the entire agreement and understanding between the parties as to the subject matter
thereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them.

&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Amendment</u>. Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived,
discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment, waiver,
discharge or termination is sought.

&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Binding upon Successors</u>. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective
heirs, legal representatives, successors and permitted assigns.

8. <u>Notices</u>. Unless otherwise provided herein, any notice or other communication to a party hereunder shall be sufficiently given
if in writing and personally delivered or sent by facsimile or other electronic transmission with copy sent in another manner herein provided
or sent by courier (which for all purposes of this Agreement shall include Federal Express or another recognized overnight courier) or
mailed to said party by certified mail, return receipt requested, at its address provided for herein or such other address as either may
designate for itself in such notice to the other. Communications shall be deemed to have been received when delivered personally,
on the scheduled arrival date when sent by next day or 2nd-day courier service, or if sent by facsimile upon receipt of confirmation of
transmittal or, if sent by mail, then three days after deposit in the mail. If given by electronic transmission, such notice shall be
deemed to be delivered (a) if by electronic mail, when directed to an electronic mail address at which the party has provided to
receive notice; and (b) if by any other form of electronic transmission, when directed to such party.

9. <u>Counterparts</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic
mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

10. <u>Survival; Severability</u> 

&nbsp;&nbsp;&nbsp;&nbsp;10.1. <u>Survival</u>. The representations, warranties, covenants and agreements of the parties hereto shall survive the closing of the
transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;10.2. <u>Severability</u>. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that no
such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

11. <u>Headings</u> *.* The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.

12. <u>Disclosure; Waiver</u>. As soon as practicable, but in no event later than one business day, after execution
of this Agreement, the Company will file a Current Report on Form 8-K under the Securities Exchange Act of 1934, as amended (the
 "Exchange Act"), reporting the execution of this Agreement. The parties to this Agreement shall cooperate with one another
to assure that such disclosure is accurate. BLUA agrees that the name of the investor shall not be included in any public disclosures
related to this Agreement unless required by applicable law, regulation or stock exchange rule .
Investor (i) acknowledges that the Sponsor may possess or have access to material non-public information which has not been communicated
to the Investor; (ii) hereby waives any and all claims, whether at law, in equity or otherwise, that he, she, or it may now have
or may hereafter acquire, whether presently known or unknown, against the Sponsor or any of BLUA's officers, directors, employees,
agents, affiliates, subsidiaries, successors or assigns relating to any failure to disclose any non-public information in connection
with the transaction contemplated by this Agreement, including any potential business combination involving BLUA, including without limitation,
any claims arising under Rule 10-b(5) of the Exchange Act; and (iii) is aware that the Sponsor is relying on the truth
of the representations set forth in Section 3 of this Agreement and the foregoing acknowledgement and waiver in this Section 12,
in connection with the transactions contemplated by this Agreement.

13. <u>Independent Nature of Rights and Obligations</u>. Nothing contained herein, and no action taken by any party pursuant hereto, shall
be deemed to constitute Investor and the Sponsor as, and the Sponsor acknowledges that Investor and the Sponsor do not so constitute,
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that Investor and the Sponsor are
in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any
matters, and the Sponsor acknowledges that Investor and the Sponsor are not acting in concert or as a group, and the Sponsor shall not
assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement.

14. <u>Most Favored Nation</u>. In the event the Sponsor enters one or more other non-redemption agreements before or after the execution
of this Agreement in connection with the Meeting, the Sponsor represents that the terms of such other agreements are not materially more
favorable to such other investors thereunder than the terms of this Agreement are in respect of the Investor. In the event that another
investor is afforded any such more favorable terms than the Investor, the Sponsor shall promptly inform the Investor of such more favorable
terms in writing, and the Investors shall have the right to elect to have such more favorable terms included herein, in which case the
parties hereto shall promptly amend this Agreement to effect the same.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

---

| |
|:---|
| **INVESTOR** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Non-Redemption Agreement]*

---

| |
|:---|
| **SPONSOR:** |
| BLUERIVER VENTURES, LLC |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Non-Redemption Agreement]*

<u>Exhibit A</u>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Investor** | &nbsp;&nbsp;**Assigned<br> Securities / <br> Economic <br> Interest Assigned** | &nbsp;&nbsp;**Number of <br> Public Shares to<br> be Held as<br> Investor Shares** |
| &nbsp;&nbsp; <br> Address:<br>SSN/EIN: | &nbsp;&nbsp; <br> [50,000] Class B <br> Ordinary Shares | &nbsp;&nbsp; <br> [200,000] Class<br> A Ordinary <br> Shares |

---

EXHIBIT B

FORM OF JOINDER

TO

LETTER AGREEMENT

AND

REGISTRATION RIGHTS AGREEMENT

______, 20_

Reference is made to that certain Non-Redemption Agreement and Assignment of Economic Interest, dated as of , 2023 (the "<u>Agreement</u>"), by and among ("<u>Investor</u>"), BlueRiver Acquisition Corp. (the "<u>Company</u>") and BlueRiver, LLC (the "<u>Sponsor</u>"), pursuant to which Investor acquired securities of the Company from the Sponsor. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Agreement.

By executing this joinder, Investor hereby agrees, as of the date first set forth above, that Investor (i) shall become a party to that certain Letter Agreement, dated January 28, 2021 (as it exists on the date of the Agreement, the "<u>Letter Agreement</u>"), by and among the Company, the Sponsor, officers and directors of the Company, and the other shareholders of the Company signatory thereto, solely with respect to Section 5(a) of the Letter Agreement, and shall be bound by, and shall be subject to the restrictions set forth under, the terms and provisions of such section of the Letter Agreement as an Insider (as defined therein) solely with respect to its Assigned Securities; and (ii) shall become a party to that certain Registration Rights Agreement, dated January 28, 2021 (as it exists on the date of the Agreement, the "<u>Registration Rights Agreement</u>"), by and among the Company, the Sponsor, and the other shareholders of the Company signatory thereto, and shall be bound by the terms and provisions of the Registration Rights Agreement as an Investor (as defined therein) and entitled to the rights of an Investor under the Registration Rights Agreement and the Assigned Securities (together with any other equity security of the Company issued or issuable with respect to any such Assigned Securities by way of a share dividend or share subdivision or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization) shall be "Registrable Securities" thereunder.

For the purposes of clarity, it is expressly understood and agreed that each provision contained herein, in the Letter Agreement (to the extent applicable to Investor) and the Registration Rights Agreement is between the Company and Investor, solely, and not between and among Investor and the other shareholders of the Company signatory thereto.

This joinder may be executed in two or more counterparts, and by facsimile, all of which shall be deemed an original and all of which together shall constitute one instrument.

---

| |
|:---|
| **[INVESTOR]** |
| By: |
| Name: |
| Title: |

---

**<u>ACKNOWLEDGED AND AGREED:</u>**

BLUERIVER ACQUISITION CORP.

By:   <br> Name: <br> Title: